Mizuho Lifts PT on Pediatrix Medical Group (MD) Following Q1 Results

Pediatrix Medical Group, Inc. (NYSE:MD) is one of the best small cap stocks to buy for 10x potential. Mizuho lifted the price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $24 from $21 on May 8, maintaining a Neutral rating on the shares. The rating update came after the company announced financial results for fiscal Q1 2026, reporting earnings of $0.36 per share for the three months ended March 31, 2026. On a non-GAAP basis, adjusted EPS came up to $0.44.

Pediatrix Medical Group, Inc. (NYSE:MD) also reported that net income came up to $30 million and adjusted EBITDA was $58 million. Net revenue was $476 million for the quarter compared to $458.4 million for the prior-year period, with the increase reflecting growth in same-unit revenue of 2.8%, and to a lesser extent, growth in non-same unit activity. Management attributed this to recent acquisitions and was partially offset by practice dispositions. In addition, Pediatrix Medical Group, Inc. (NYSE:MD) reported that same-unit revenue from net reimbursement-related factors rose by 4.4% for fiscal Q1 2026, as compared to the prior-year period.

Pediatrix Medical Group, Inc. (NYSE:MD) provides physician services, including neonatal care, maternal fetal care, and other pediatric subspecialty care.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.